Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenprocoumon versus Dabigatran in atrial fibrillation with left atrial thrombus
2014-002236-14Phase 4Terminated
- Sponsor
- University Hospital Ulm
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) and left atrial thrombosis comparing Phenprocoumon arm with Dabigatran arm (2 arms). Started Aug 2015; status: terminated.
02
Drugs
dabigatranphenprocoumon
03
Conditions
Atrial fibrillation (AFib)left atrial thrombosis
Beyond the preview
Go deeper on 2014-002236-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002236-14.